5-Hydroxy-2-hydroxymethyl-4-pyrone (KOJIC ACID)
Commonly Found In
Overview
Kojic acid is a natural fungal metaboliteβmost commonly derived from Aspergillus oryzae fermentationβthat has been widely studied and used as a skin-brightening active in cosmetics. Its primary mechanism of action involves chelating copper ions at the active site of tyrosinase, the enzyme responsible for melanin biosynthesis, thereby reducing melanin production and helping to fade hyperpigmentation, dark spots, and post-inflammatory discoloration. Clinical evidence indicates it is effective for treating melasma and acne-related discoloration, though studies suggest it may cause mild contact sensitization in some individuals, particularly at higher concentrations. Japan recognizes kojic acid as an approved quasi-drug whitening active, reflecting its established regulatory and commercial history in Asian markets; the EU banned it in 2003 but re-authorized it in 2015 at up to 1% in leave-on face products following a re-evaluation by SCCS.
Also known as: 5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one, 5-Hydroxy-2-hydroxymethyl-4-pyrone, Kojic Acid, KA
Key Benefits
Clinical evidence indicates kojic acid effectively reduces melanin synthesis by chelating the copper ions essential for tyrosinase activity. Studies suggest it may help visibly reduce the appearance of dark spots, melasma, and post-inflammatory hyperpigmentation with consistent use, typically at 1-4% concentrations. Some research indicates additive effects when combined with other brightening agents such as vitamin C or arbutin.
Supporting Research
- β’ Lim JT (1999). Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatologic Surgery, 25(4), 282-284. Demonstrated significant lightening of melasma lesions compared to baseline.
- β’ Noh TK et al. (2013). Topical application of kojic acid inhibits proliferation and differentiation of melanocytes. Annals of Dermatology, 25(3), 332-338. Confirmed tyrosinase inhibition mechanism in human melanocytes.
- β’ Saeedi M et al. (2019). The applications of kojic acid in cosmetics and pharmaceuticals. Biomedicine & Pharmacotherapy, 110, 582-593. Comprehensive review of brightening efficacy and safety profile.
Skin Compatibility Ratings
Comedogenic Rating
Non-comedogenic at typical cosmetic use concentrations.
Source: Draelos ZD & DiNardo JC (2006). A re-evaluation of the comedogenicity concept. JAAD, 54(3), 507-512.
Irritancy Rating
Mild irritation and contact sensitization reported in some individuals, particularly at concentrations above 1%. Contact dermatitis cases have been documented. Risk is manageable at the EU-permitted 1% maximum.
Source: SCCS Opinion SCCS/1622/21 and Saeedi M et al. (2019). Biomedicine & Pharmacotherapy, 110, 582-593.
Typical Use Concentration
Range
0.5-4%
Optimal
1-2%
EU maximum is 1% in face leave-on products and 0.2% in body/hand leave-on products. Japan allows it as a quasi-drug whitening active. Higher concentrations (up to 4%) used in some Asian OTC products and professional treatments.
Works Well With / Avoid
Works Well With
Use With Caution
Kojic acid may oxidize and discolor (turn pinkish-brown) when exposed to air or iron ions; chelating agents in formulations help maintain stability. Patch testing is advisable for sensitive skin users.
Commonly Found In
Global Regulation Summary
Overview of current status across major international markets.
Detailed Regional Status
| Region | Status | Max Conc. | Conditions | Source |
|---|---|---|---|---|
| πͺπΊ EU | Unknown | - | - | Official β |
| πΊπΈ USA | Unknown | - | - | Official β |
| π―π΅ Japan | Unknown | - | - | Official β |
| π°π· Korea | Unknown | - | - | Official β |
| π¬π§ UK | Unknown | - | - | Official β |
π Why Regulations Differ
Kojic acid has a notably complex regulatory history. The EU banned it in 2003 due to concerns about mutagenicity data; after a re-evaluation by SCCS, it was re-authorized in 2015 (Commission Regulation (EU) 2015/1190) at 1% in face leave-on products and 0.2% in hand and body leave-on products, with a labeling requirement. Japan's MHLW approved kojic acid as a quasi-drug whitening active, recognizing its long history of safe use in Japanese cosmetics with traditional association with sake fermentation. The US permits it in cosmetics without a specific concentration cap under current FDA regulations, relying on manufacturer responsibility.
Recent Regulatory Changes
- β’ EU re-authorization of kojic acid at 1% (face leave-on) via Commission Regulation (EU) 2015/1190.
- β’ EU SCCS Opinion SCCS/1622/21 on the safety of kojic acid β reaffirmed conditions for safe use.
Regulation Analysis
Category Comparison
97% of SKIN CONDITIONING ingredients (378 of 389) are banned in the EU, but this one is approved.
πΏ Natural Sources
Produced by Aspergillus species fungi, particularly Aspergillus oryzae ('koji-kin' in Japanese). By-product in fermentation of malting rice for sake (Japanese rice wine), shoyu (soy sauce), miso, and vinegar production. Aspergillus oryzae has been used in Japanese food fermentation for over 2,000 years.
π How It's Made
Produced by fermentation using Aspergillus flavus or A. oryzae. Optimal production: malt extract sucrose (MES) medium, pH 4, 30Β°C, 7 days incubation. High yields (>15 g/L) achieved by only 3 A. flavus isolates. Maximum titer of 25.71 g/L in pH-controlled bioreactors. First isolated in 1907 by Saito from A. oryzae on steamed rice; named by Yabuta in 1912.
π Uses in Cosmetics
Skin-lightening agent that inhibits melanin formation by blocking tyrosinase enzyme. Provides UV light protective action. Extends product shelf life through preservative action against chemical and microbial degradation. Used in brightening creams, serums, and anti-aging products. Forms bright red complex with ferric ions.
π¬ Other Applications
Food industry: prevents oxidative browning on cut fruits, preserves pink/red colors in seafood, flavor enhancer precursor, prevents nitrosopyrrolidine formation in fried bacon. Agricultural: prevents melanosis (blackening) in produce. Pharmaceutical: antimicrobial, antiviral, antitumor, antidiabetic, anticancer, anti-parasitic, and insecticidal properties.
π‘ Fun Facts
- β’ First isolated in 1907 by Saito from Aspergillus oryzae grown on steamed rice - the first compound ever isolated from this fungus
- β’ Named 'kojic acid' in 1912 by Yabuta from 'koji' (ιΊΉ), the Japanese starter culture used for over 2,000 years in sake, soy sauce, and miso production
- β’ Chemical structure not deciphered until 1924 - took 12 years after isolation to understand its molecular composition
Related Skin Concerns
Data Sources
- β’ Saeedi M et al. (2019). Biomedicine & Pharmacotherapy, 110, 582-593.
- β’ Lim JT (1999). Dermatologic Surgery, 25(4), 282-284.
- β’ EU SCCS Opinion SCCS/1622/21.
- β’ Commission Regulation (EU) 2015/1190 on kojic acid.
- β’ MHLW Japan quasi-drug whitening active approvals.
- β’ Draelos ZD & DiNardo JC (2006). JAAD, 54(3), 507-512.
Last data verification: 2026-04-12
Related Ingredients
Ξ±-Arbutin
ALPHA-ARBUTIN
Beta-Arbutin
ARBUTIN
Nonanedioic Acid
AZELAIC ACID
CANNABIDIOL - DERIVED FROM EXTRACT OR TINCTURE OR RESIN OF CANNABIS
CANNABIDIOL - SYNTHETICALLY PRODUCED
CANNABIS SATIVA FLOWER/LEAF/STEM EXTRACT
Learn More
Frequently Asked Questions
What is KOJIC ACID used for in cosmetics?
KOJIC ACID is primarily used for skin conditioning in cosmetic products. It also serves as skin brightening, antioxidant. The ingredient is commonly found in moisturizers, lotions, and creams.
Which countries regulate KOJIC ACID?
KOJIC ACID is approved for cosmetic use in all major markets: , with no significant restrictions.
Where can I find official regulation information about KOJIC ACID?
Official information about KOJIC ACID regulations can be found on government websites: EU CosIng database, US FDA Cosmetics page, Japan MHLW cosmetics standards, UK Government cosmetics guidance, and Korea MFDS. Always verify regulatory status with these official sources before making formulation decisions.
Disclaimer
The information on this website is for educational and informational purposes only and is not intended as medical advice. While we strive for accuracy based on official government databases, cosmetic regulations change frequently. Always consult with a qualified professional or refer to the latest official regulatory documents for compliance. We are not responsible for any actions taken based on the information provided here.